Rongzhen Xu Selected Research

Rongzhen Xu Research Topics

Disease

21	Neoplasms (Cancer) 11/2023 - 12/2007
14	Leukemia 01/2022 - 11/2005
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 06/2015
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2017 - 01/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 12/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2019 - 09/2017
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 09/2017 - 05/2015
2	Neoplasm Metastasis (Metastasis) 09/2017 - 12/2010
2	Lung Neoplasms (Lung Cancer) 06/2015 - 11/2010
2	Infections 01/2008 - 03/2007
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2024
1	Bites and Stings (Sting) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Lymphoma (Lymphomas) 10/2017
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2017
1	Blast Crisis (Blast Phase) 09/2017
1	Myeloid Leukemia (Leukemia, Myelocytic) 09/2017
1	Stroke (Strokes) 04/2016
1	Heart Failure 04/2016
1	Hemorrhage 04/2016
1	Ischemic Stroke 04/2016
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2015
1	Gouty Arthritis 07/2014
1	Gout 07/2014
1	Liver Neoplasms (Liver Cancer) 10/2013
1	Colorectal Neoplasms (Colorectal Cancer) 05/2013
1	Lymphoid Leukemia 08/2012
1	Adenocarcinoma of Lung 08/2012
1	Colonic Neoplasms (Colon Cancer) 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 12/2007
1	Carcinogenesis 12/2007
1	Hepatitis 03/2007

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2005
7	berbamine (penduline)IBA 01/2020 - 01/2006
6	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2018 - 05/2013
3	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2017 - 12/2012
3	Messenger RNA (mRNA)IBA 01/2016 - 05/2013
3	bcr-abl Fusion ProteinsIBA 06/2015 - 01/2006
2	Transcription Factors (Transcription Factor)IBA 02/2024 - 09/2019
2	Cytidine DeaminaseIBA 01/2022 - 12/2007
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 12/2012
2	fms-Like Tyrosine Kinase 3IBA 01/2021 - 06/2019
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2016
2	EnzymesIBA 09/2019 - 03/2007
2	HomoharringtonineIBA 06/2019 - 06/2015
2	CateninsIBA 06/2015 - 05/2015
2	Imatinib Mesylate (Gleevec)FDA Link 08/2009 - 01/2006
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2007 - 11/2005
2	Tyrosine (L-Tyrosine)FDA Link 04/2007 - 11/2005
1	Cyclin AIBA 01/2022
1	ATP dependent 26S protease (26S proteasome)IBA 01/2022
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2022
1	UbiquitinIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Cyclin-Dependent Kinase 2IBA 01/2022
1	APOBEC-1 DeaminaseIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	triptonideIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	4-toluenesulfonyl chlorideIBA 09/2019
1	tanespimycin (17AAG)IBA 06/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2019
1	AlkaloidsIBA 06/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2018
1	Dendrimers (Dendrons)IBA 09/2017
1	Ethylene Glycol (Monoethylene Glycol)IBA 09/2017
1	Blood Glucose (Blood Sugar)IBA 04/2016
1	Warfarin (Coumadin)FDA LinkGeneric 04/2016
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2016
1	Nuclear RNAIBA 01/2016
1	Eukaryotic Initiation Factor-4EIBA 06/2015
1	Serine (L-Serine)FDA Link 06/2015
1	Phosphotransferases (Kinase)IBA 06/2015
1	Notch1 ReceptorIBA 05/2015
1	triptolideIBA 05/2015
1	Uric Acid (Urate)IBA 07/2014
1	Small Interfering RNA (siRNA)IBA 10/2013
1	Protein Isoforms (Isoforms)IBA 05/2013
1	Glucose (Dextrose)FDA LinkGeneric 08/2012
1	GlycosidesIBA 08/2012
1	His Transfer RNAIBA 01/2012
1	Cadherins (E-Cadherin)IBA 12/2010
1	MicroRNAs (MicroRNA)IBA 12/2010
1	Cisplatin (Platino)FDA LinkGeneric 11/2010
1	polyphyllin IIBA 11/2010
1	Histone Deacetylase InhibitorsIBA 10/2010
1	hydrogen sulfite (bisulfite)IBA 10/2010
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2010
1	linaloolIBA 01/2010
1	Monoterpenes (Monoterpenoids)IBA 01/2010
1	NF-kappa B (NF-kB)IBA 08/2009
1	ElementsIBA 05/2009
1	CytidineIBA 12/2007
1	AntigensIBA 12/2007
1	ImmunosorbentsIBA 03/2007

Therapy/Procedure

8	Therapeutics 11/2023 - 10/2013
1	Drug Therapy (Chemotherapy) 01/2020
1	Oral Administration 09/2019
1	Aftercare (After-Treatment) 04/2016